Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-05-05 | Mr. Johannes Van HouteCFO | -14,06k | 233,32k | Automatic Disposition | 16,58 - 17,18 | 37,59k | -27,21% |
| 2026-05-04 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -8,15k | 138,21k | Automatic Disposition | 16,96 | 18,31k | -30,80% |
| 2026-05-01 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -5,39k | 90,41k | Automatic Disposition | 16,76 | 26,45k | -16,94% |
| 2026-04-30 | Mr. Johannes Van HouteCFO | -2,39k | 39,75k | Derivative Exercise and Sale | 16,65 | 51,65k | - |
| 2026-04-30 | Mr. Johannes Van HouteCFO | 6,22k | 0,00 | Derivative Exercise and Retained Stock | - | 51,65k | 13,69% |
| 2026-04-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,21k | 53,50k | Derivative Exercise and Sale | 16,65 | 31,85k | - |
| 2026-04-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 5,39k | 0,00 | Derivative Exercise and Retained Stock | - | 31,85k | 20,39% |
| 2026-04-30 | Dr. Gwenn M. HansenChief Scientific Officer | -3,21k | 53,50k | Derivative Exercise and Sale | 16,65 | 120,40k | - |
| 2026-04-30 | Dr. Gwenn M. HansenChief Scientific Officer | 5,39k | 0,00 | Derivative Exercise and Retained Stock | - | 120,40k | 4,69% |
| 2026-04-02 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -8,15k | 124,15k | Automatic Disposition | 15,24 | 26,45k | -23,55% |
| 2026-03-02 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -8,15k | 125,79k | Automatic Disposition | 15,44 | 34,60k | -19,06% |
| 2026-02-09 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -14,26k | 237,62k | Automatic Disposition | 16,66 | 42,75k | -25,01% |
| 2026-02-03 | Dr. Gwenn M. HansenChief Scientific Officer | 31,33k | 26,32k | Derivative Exercise and Retained Stock | 0,84 | 115,01k | 37,45% |
| 2026-01-30 | Mr. Johannes Van HouteCFO | 7,84k | 0,00 | Derivative Exercise and Retained Stock | - | 45,43k | 20,84% |
| 2026-01-30 | Mr. Johannes Van HouteCFO | -3,66k | 60,77k | Derivative Exercise and Sale | 16,58 - 17,37 | 45,43k | - |
| 2026-01-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 6,11k | 0,00 | Derivative Exercise and Retained Stock | - | 57,01k | 12,01% |
| 2026-01-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -4,42k | 73,38k | Derivative Exercise and Sale | 16,58 - 17,37 | 57,01k | - |
| 2026-01-30 | Dr. Gwenn M. HansenChief Scientific Officer | 6,92k | 0,00 | Derivative Exercise and Retained Stock | - | 83,67k | 9,02% |
| 2026-01-30 | Dr. Gwenn M. HansenChief Scientific Officer | -4,90k | 81,25k | Derivative Exercise and Sale | 16,58 - 17,37 | 83,67k | - |
| 2026-01-20 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,76k | 62,28k | Derivative Exercise and Sale | 1,86 - 18,42 | 50,90k | - |
| 2025-12-18 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,76k | 60,32k | Derivative Exercise and Sale | 1,86 - 18,56 | 50,90k | - |
| 2025-11-24 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -37,60k | 571,76k | Derivative Exercise and Sale | 1,86 - 17,07 | 50,90k | - |
| 2025-11-03 | Mr. Johannes Van HouteCFO | -6,28k | 78,93k | Automatic Disposition | 12,56 | 37,59k | -14,32% |
| 2025-10-30 | Mr. Johannes Van HouteCFO | 8,36k | 0,00 | Derivative Exercise and Retained Stock | - | 43,88k | 23,55% |
| 2025-10-30 | Mr. Johannes Van HouteCFO | -3,13k | 40,05k | Derivative Exercise and Sale | 12,80 | 43,88k | - |
| 2025-10-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 6,89k | 0,00 | Derivative Exercise and Retained Stock | - | 50,90k | 15,65% |
| 2025-10-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,64k | 46,63k | Derivative Exercise and Sale | 12,80 | 50,90k | - |
| 2025-10-30 | Dr. Gwenn M. HansenChief Scientific Officer | 7,73k | 0,00 | Derivative Exercise and Retained Stock | - | 76,75k | 11,20% |
| 2025-10-30 | Dr. Gwenn M. HansenChief Scientific Officer | -4,09k | 52,30k | Derivative Exercise and Sale | 12,80 | 76,75k | - |
| 2025-09-17 | Ms. Julia Paige GregoryIndependent Chairman | 10,75k | 20,00k | Derivative Exercise and Retained Stock | 1,86 | 10,75k | - |
| 2025-08-01 | Mr. Johannes Van HouteCFO | -5,40k | 59,60k | Automatic Disposition | 11,03 | 35,51k | -13,20% |
| 2025-07-30 | Dr. Gwenn M. HansenChief Scientific Officer | 7,51k | 0,00 | Derivative Exercise and Retained Stock | - | 69,02k | 12,20% |
| 2025-07-30 | Dr. Gwenn M. HansenChief Scientific Officer | -4,31k | 51,74k | Derivative Exercise and Sale | 12,01 | 69,02k | - |
| 2025-07-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | 6,69k | 0,00 | Derivative Exercise and Retained Stock | - | 44,01k | 17,93% |
| 2025-07-30 | Dr. Christine RingChief Legal Officer, Secretary & CCO | -3,84k | 46,13k | Derivative Exercise and Sale | 12,01 | 44,01k | - |
| 2025-07-30 | Mr. Johannes Van HouteCFO | 7,19k | 0,00 | Derivative Exercise and Retained Stock | - | 40,91k | 21,32% |
| 2025-07-30 | Mr. Johannes Van HouteCFO | -4,30k | 51,70k | Derivative Exercise and Sale | 12,01 | 40,91k | - |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
